Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Ingevity (NGVT)

Ingevity Q1 sales fall 17% to $284.0 million; adjusted EBITDA rises 23%

Mixed Impact 3 of 5 earnings Written later

Ingevity reported first-quarter 2025 net sales of $284.0 million, down 17%, mainly due to repositioning of its Performance Chemicals segment. Net income was $20.5 million, or $0.56 per diluted share, compared with a net loss of $56.0 million a year earlier, and adjusted EBITDA rose 23% to $91.3 million. The company widened its full-year 2025 guidance to sales of $1.25 billion to $1.40 billion and adjusted EBITDA of $380 million to $415 million, citing lower auto production forecasts tied to trade tensions.

Key points

  • Q1 net sales were $284.0 million, down 17%, with Performance Chemicals sales down 35% to $95.0 million.
  • Net income was $20.5 million ($0.56 per diluted share) after $20.2 million in before-tax special charges; adjusted EPS was $0.99.
  • Adjusted EBITDA was $91.3 million, up 23%, with an adjusted EBITDA margin of 32.1%.
  • Full-year 2025 guidance: sales of $1.25 billion to $1.40 billion and adjusted EBITDA of $380 million to $415 million; no share repurchases were made in the quarter.

The filing

CompanyIngevity (NGVT)
Form8-K, current report
Filed with the SECMay 5, 2025, 4:17 PM ET
Accession number0001653477-25-000062

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:54 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 05, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.